Target intelligence / Profile preview

MicroRNA 1282 (MIR1282)

Target
MIR1282
Molecular classification
Other (specifically, microRNA / non-coding RNA regulator)
01

Overview

MicroRNA 1282 (MIR1282) is a small, non-coding RNA molecule encoded by the human MIR1282 gene. It functions as a post-transcriptional regulator by binding to complementary sequences in targeted messenger RNAs, leading to repression of gene expression through mRNA degradation or translation inhibition. Like other microRNAs, MIR1282 is produced through the canonical microRNA biogenesis pathway, involving Drosha and Dicer processing, and is incorporated into the RNA-induced silencing complex (RISC) to mediate its effects. Although the specific biological and pathological roles of MIR1282 are not comprehensively characterized in the literature, the microRNA family as a whole is recognized for regulating processes such as cell proliferation, apoptosis, differentiation, and disease pathogenesis, including cancer.

Other names
hsa-mir-1282MIRN1282
02

Mechanism of action

For general microRNA-targeting drugs: Inhibition of miRNA maturation or function (using antisense oligonucleotides); miRNA sponges or decoys that competitively bind MIR1282, sequestering its activity; miRNA mimics to restore or replace MIR1282 function if lost.

03

Biological functions

Post-transcriptional gene silencingRegulation of mRNA stability and translationGene expression regulation
04

Disease associations

CancerOther (microRNAs commonly modulate pathways involved in diverse diseases)
05

Safety considerations

None specifically attributed to MIR1282.For miRNA-targeting agents in general, off-target effects and broad impact on gene networks can present challenges.

Beyond the preview

Go deeper on MicroRNA 1282 (MIR1282).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 1282 (MIR1282).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call